Why Semaglutide, Tirzepatide, and Retatrutide Work Differently

I spend a lot of time studying how these compounds actually work, and one thing I see misunderstood all the time is that people assume all of these peptides work the same way.

Most people lump everything together and just call them “GLP-1s.”

But that’s not really how it works.

Different compounds activate different hormone pathways in the body, and those pathways influence appetite, metabolism, and energy use in different ways.

Once you understand the pathways involved, the differences between these compounds start to make a lot more sense.

Let’s break it down in simple terms.

GLP-1: The Appetite Control Pathway

GLP-1 is the hormone most people are familiar with.

When GLP-1 receptors are activated, the body sends stronger satiety signals to the brain. In plain English, that means you feel full faster and stay full longer.

GLP-1 activity can:

• reduce hunger

• slow stomach emptying

• increase feelings of fullness

• decrease food cravings

This is why compounds that mainly target GLP-1 tend to feel like strong appetite suppressants.

Semaglutide is a good example of this. Its primary mechanism is GLP-1 activation, so most of the effect people notice is simply not being as hungry.

GIP: Metabolic Signaling

GIP is another hormone involved in how the body processes nutrients.

Instead of focusing mainly on hunger signals, GIP plays a bigger role in metabolic regulation and insulin signaling.

When GIP receptors are activated, it can influence things like:

• how the body handles glucose

• insulin response

• how nutrients are used for energy

On its own, GIP isn’t known for dramatic appetite suppression. But when combined with GLP-1 activity, it can improve overall metabolic signaling.

This is why compounds that activate both GLP-1 and GIP often feel a little different compared to GLP-1 alone.

Glucagon: Energy Expenditure

The third pathway getting more attention recently is the glucagon receptor.

Glucagon works differently from the other two pathways. Instead of mainly influencing hunger signals, it affects how the body uses stored energy.

Activation of glucagon receptors can:

• increase energy expenditure

• promote fat breakdown

• encourage the body to burn stored fuel

So instead of just eating less, the body may also be using more energy.

Why Different Peptides Feel Different

Once you understand the hormone pathways involved, it becomes easier to see why different compounds can feel very different.

Some compounds primarily activate GLP-1, which means their biggest impact is appetite suppression.

Others activate GLP-1 and GIP, adding metabolic signaling.

And some of the latest compounds activate GLP-1, GIP, and glucagon, influencing appetite, metabolism, and energy use at the same time.

Compound Comparison

This chart shows the relative receptor pathway activity of several commonly discussed metabolic peptides.

Relative pathway activity based on current research mechanisms.

↑ = relative pathway activity

GLP-1 = appetite suppression

GIP = metabolic signaling

Glucagon = energy expenditure

The Takeaway

Not all peptides in this category work the same way.

Some primarily reduce hunger.

Others influence multiple hormone pathways involved in metabolism, energy use, and fat utilization.

Understanding these differences helps explain why experiences can vary depending on which pathways are activated.

As research continues, scientists are learning that combining hormone pathways may play a bigger role in metabolic outcomes than targeting just one pathway alone.

Disclaimer

All products available at TM Research are strictly for research use only and are not intended for human consumption.